Daily Sepsis Research Analysis
Analyzed 19 papers and selected 3 impactful papers.
Summary
Three impactful sepsis studies span epidemiology, prevention, and data-driven quality improvement. A registered meta-analysis (>3.3 million patients) links new-onset atrial fibrillation in sepsis to higher mortality and stroke; a prospective Dutch cohort of infant Group B streptococcal disease quantifies serotype distribution and high potential vaccine coverage; and a multicenter EMR algorithm advances earlier, automated detection of sepsis time-zero for SEP-1 monitoring.
Research Themes
- Cardiac complications and outcomes in sepsis
- Maternal-infant GBS prevention and vaccine coverage
- EMR/NLP methods for precise sepsis time-zero detection
Selected Articles
1. Sepsis, atrial fibrillation and mortality risk: an updated systematic review and meta-analysis of >3 million patients.
Across >3.3 million patients, new-onset atrial fibrillation occurred in about 13% of septic patients (rising to ~21% in ICUs) and was associated with higher mortality and ischemic stroke risk. Associations were consistent but varied in magnitude across sepsis definitions, underscoring the robustness and heterogeneity of the signal.
Impact: This high-powered, registered meta-analysis quantifies the burden and prognostic significance of NOAF in sepsis, informing surveillance and management strategies. It consolidates heterogeneous literature into actionable risk estimates.
Clinical Implications: Clinicians should proactively monitor for AF in septic patients, particularly in ICUs, and consider rhythm/rate control and post-discharge thromboembolic risk assessment. Findings support integrating AF surveillance into sepsis pathways and post-ICU follow-up.
Key Findings
- NOAF prevalence in sepsis was 13.27% overall, reaching 21.47% in ICUs.
- NOAF was associated with higher all-cause mortality (OR 2.22) and ischemic stroke (OR 1.17).
- Effect sizes varied by sepsis definition (ICD codes, Sepsis-2, Sepsis-3, clinical criteria), but the adverse association persisted.
Methodological Strengths
- Registered protocol (PROSPERO) and broad database search across MEDLINE and EMBASE.
- Very large aggregated sample (>3.3 million) enabling precise risk estimates and stratified analyses by care setting and sepsis definition.
Limitations
- Heterogeneity across included studies and reliance on observational data and coding/definitions.
- Limited guidance on optimal AF management strategies (e.g., anticoagulation) within sepsis from included studies.
Future Directions: Prospective studies and trials should evaluate prevention and treatment strategies for NOAF in sepsis, including rhythm control and anticoagulation thresholds tailored to bleeding risk.
OBJECTIVES: To evaluate the new-onset atrial fibrillation (NOAF) prevalence and the overall, in-hospital, post-discharge mortality, and ischemic stroke risk associated with NOAF in septic patients. METHODS: Systematic review and meta-analysis of studies reporting the prevalence and risk of NOAF in patients with sepsis (PROSPERO CRD420261284949). MEDLINE and EMBASE were searched from inception to 31 RESULTS: 15 including 3,323,792 patients were analyzed. The NOAF prevalence was 13.27% (95%CI 8.16-19.4, p<0.001), from 6.74% in ordinary hospitalizations to 21.47% in intensive care units. Sepsis was associated with NOAF risk (OR 3.95, 95%CI 1.53-10.22, p<0.001). NOAF patients had higher all-cause mortality risk (OR 2.22, 95%CI 1.63-3.03, p<0.001), either in-hospital (OR 2.21, 95%CI 2.00-2.45, p<0.001), or post-discharge (OR 1.32, 95%CI 1.12-1.57, p<0.001), and ischemic stroke (OR 1.17, 95%CI 1.09-1.25, p<0.001). Mortality risk varied according to sepsis definition by ICD code (OR 2.13, 95%CI 1.29-3.52, p<0.001), Sepsis-2 (OR 4.52, 95%CI 2.24-9.09, p<0.001), Sepsis-3 (OR 1.64, 95%CI 1.21-2.22, p=0.002) and clinical criteria (OR 2.46, 95%CI 1.17-5.18, p=0.02). CONCLUSIONS: NOAF is a frequent cardiac complication of septic patients and is associated with increased mortality and stroke risk.
2. CLINICAL CHARACTERISTICS, OUTCOMES AND MOLECULAR EPIDEMIOLOGY OF GROUP B STREPTOCOCCAL DISEASE IN YOUNG INFANTS IN THE NETHERLANDS.
In a prospective multicenter cohort of 375 infants with GBS disease, serotype III predominated and was linked to meningitis and late-onset disease. Despite a 5% mortality and frequent complications, only 40% of eligible mothers received intrapartum antibiotic prophylaxis; candidate maternal vaccines could cover 96–99% of strains.
Impact: This study integrates outcomes, serotype epidemiology, and vaccine coverage in infant GBS disease, directly informing prevention strategies, including maternal vaccination and intrapartum prophylaxis adherence.
Clinical Implications: Enhance adherence to intrapartum antibiotic prophylaxis and prioritize maternal GBS vaccination strategies, particularly targeting serotype III. Implement robust perinatal screening and post-discharge follow-up for neurological sequelae.
Key Findings
- Among 375 infants, 55% had sepsis; 21% definitive and 24% probable meningitis; mortality was 5%.
- Serotype III (57%) predominated and was associated with meningitis and late-onset disease.
- Only 40% of eligible mothers received intrapartum antibiotic prophylaxis; candidate maternal vaccines could cover 96–99% of strains.
Methodological Strengths
- Prospective, multicenter design with comprehensive clinical and microbiological characterization.
- Integration of serotype data with modeled vaccine coverage to inform prevention policy.
Limitations
- National cohort limits generalizability beyond the Netherlands’ epidemiology.
- Outcomes assessed at discharge; long-term neurodevelopmental sequelae were not captured.
Future Directions: Evaluate maternal GBS vaccination implementation, improve intrapartum prophylaxis adherence, and establish long-term neurodevelopmental follow-up registries.
OBJECTIVES: Group B streptococcus (GBS) disease remains a major cause of morbidity and mortality in young infants. We conducted a prospective multi-centre cohort study to evaluate clinical outcomes, molecular epidemiology, and coverage of potential maternal vaccines candidates in the Netherlands. METHODS: Between January 1 RESULTS: We included 375 infants; 212 (57%) had early-onset disease (0-6 days) and 163 (43%) late-onset disease (7-89 days). Overall, 205 (55%) infants had sepsis, 78 (21%) definitive meningitis, and 92 (24%) probable meningitis. Complications occurred in 220 (59%) infants; 331 (88%) recovered without abnormalities at discharge. Mortality was 5%. Among mothers eligible for intrapartum antibiotic prophylaxis, 40% received prophylaxis. Serotype III was most common (57%), followed by Ia (17%) and V (8%). Serotype III was associated with meningitis and late-onset disease. Potential coverage was 96% for the GBS6 vaccine and 99% for GBS-AlpN. CONCLUSIONS: GBS disease in young infants remains associated with high morbidity and mortality. Limited adherence to intrapartum antibiotic prophylaxis highlights prevention gaps and supports maternal GBS vaccination.
3. Development and validation of an algorithm to identify severe sepsis onset from electronic medical records.
A multicenter-validated EMR algorithm that integrates structured data with unstructured notes identified documentation of infection earlier than human abstractors (mean −0.33 hours), producing an earlier time-zero. This supports scalable, automated SEP-1 monitoring and research alignment.
Impact: Methodological innovation enables consistent, earlier identification of sepsis onset using routinely collected EMR data, a prerequisite for accurate quality metrics and time-sensitive research.
Clinical Implications: Automated time-zero detection can standardize SEP-1 measurement, trigger timely bundles, and reduce manual abstraction burden; integration of clinical notes is key.
Key Findings
- Algorithm combined structured SIRS/organ dysfunction timelines with infection documentation extracted from structured data and unstructured notes.
- Across 2,030 adjudicated cases, documentation of infection was detected earlier than human abstractors on average (−0.33 hours; 95% CI −0.55 to −0.11).
- Earlier DOI led to an earlier sepsis time-zero and supports scalable SEP-1 monitoring and research use.
Methodological Strengths
- Use of unstructured clinical notes in addition to structured data improved detection.
- Validation against manually abstracted multicenter cases enhances credibility and generalizability within the health system.
Limitations
- Generalizability beyond the source health system is uncertain and depends on local documentation practices.
- Earlier detection reflects documentation timing; impact on clinical outcomes remains to be tested.
Future Directions: External validation across diverse EMRs, open benchmarking, and interventional studies testing whether algorithm-triggered bundles improve outcomes.
OBJECTIVE: To develop and evaluate an automated algorithm to identify sepsis onset, referred to as time-zero (t MATERIALS AND METHODS: We developed an algorithm to construct a comprehensive timeline of systemic inflammatory response syndrome (SIRS) criteria and organ dysfunction (OD) using structured data, and documentation of infection (DOI) using both structured data and unstructured clinical notes. Algorithm performance was assessed using 2030 manually abstracted adult sepsis cases from a multicenter health system in southeast Michigan. RESULTS: On average, the algorithm DOI time was significantly earlier than abstractors (mean: -0.33 hour, 95% Cl, -0.55 to -0.11), resulting in a significantly earlier t DISCUSSION: Automated approaches to analyzing EMR data offer a scalable framework for SEP-1 monitoring, research, and quality improvement. CONCLUSION: Incorporating unstructured clinical notes improves DOI detection.